Adjuvant treatment of malignant melanoma with DTIC + estracyt or BCG
Data up to Jan 2025
Total Citations Per Year
Abstract
References (21)
Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma
1970 • 2,415 citations
The histogenesis and biologic behavior of primary human malignant melanomas of the skin.
1969 • 2,098 citations
EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.
1964 • 763 citations
ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIA
1969 • 606 citations
A Multifactorial Analysis of Melanoma
1978 • 575 citations
BCG lmmunotherapy of Malignant Melanoma
1974 • 430 citations
Immunotherapy of Cancer: Regression of Intradermal Tumors and Prevention of Growth of Lymph Node Metastases After Intralesional Injection of Living <italic>Mycobacterium bovis</italic>
1972 • 355 citations
A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous Melanoma
1982 • 282 citations
ŒSTROGEN RECEPTORS IN HUMAN MALIGNANT MELANOMA
1976 • 220 citations
Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma IV. Late results after complete response to chemotherapy (central oncology group protocols 7130, 7131, and 7131A)
1984 • 169 citations
Results of Treatment of 269 Patients with Primary Cutaneous Melanoma
1977 • 156 citations
Chemotherapy of malignant melanoma
1972 • 134 citations
Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant Melanoma
1971 • 130 citations
DTIC and combination therapy for melanoma: III. DTIC (NSC 45388) surgical adjuvant study COG PROTOCOL 7040
1981 • 126 citations
RESULTS OF GROIN DISSECTION FOR MALIGNANT MELANOMA IN 220 PATIENTS.
1964 • 122 citations
MALIGNANT MELANOMA: AN ANDROGEN-DEPENDENT TUMOUR?
1980 • 89 citations
Results of Regional Lymph Node Dissection for Melanoma
1974 • 80 citations
Prognostic Value of Lymph Node Dissection in Malignant Melanoma
1980 • 74 citations
Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical stage I
1985 • 55 citations
Estrogen and progesterone receptors and tamoxifen in malignant melanoma.
1980 • 51 citations
Deleted Work
1955 • 0 citations